Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership854,374 shares
Latest Disclosed Value $ 56,311,790
Bnp Paribas Arbitrage, Sa reports 47.34% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 854,374 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $46,136,196 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 579,862 shares of Cytokinetics, Incorporated. This represents a change in shares of 47.34% during the quarter. The current value of the position is $53,244,588 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Cytokinetics Equity 23282W605 854,374 274,512 47.34 56,312 52.84 0.0028
2026-02-10 2025-12-31 13F Cytokinetics Equity 23282W605 579,862 332,397 134.32 36,844 170.91 0.0167
2025-11-13 2025-09-30 13F Cytokinetics Equity 23282W605 247,465 -42,780 -14.74 13,601 41.83 0.0073
2025-08-14 2025-06-30 13F Cytokinetics Equity 23282W605 290,245 52,647 22.16 9,590 0.42 0.0055
2025-05-14 2025-03-31 13F Cytokinetics Equity 23282W605 237,598 212,951 864.00 9,549 723.90 0.0056
2025-02-14 2024-12-31 13F Cytokinetics Equity 23282W605 24,647 -15,645 -38.83 1,159 -45.51 0.0006
2024-11-13 2024-09-30 13F Cytokinetics Equity 23282W605 40,292 -15,629 -27.95 2,127 -29.78 0.0014
2024-08-13 2024-06-30 13F Cytokinetics Equity 23282W605 55,921 -115,630 -67.40 3,030 -74.81 0.0025
2024-05-01 2024-03-31 13F Cytokinetics Equity 23282W605 171,551 -27,335 -13.74 12,027 -27.57 0.0106
2024-02-14 2023-12-31 13F/A-2 Cytokinetics Equity 23282W605 198,886 96,081 93.46 16,605 448.35 0.0189
2024-02-07 2023-12-31 13F/A-1 Cytokinetics Equity 23282W605 198,886 96,081 16,605 0.0023
2024-02-07 2023-12-31 13F Cytokinetics Equity 23282W605 198,886 16,605
2023-11-14 2023-09-30 13F Cytokinetics Equity 23282W605 102,805 46,856 83.75 3,029 65.92 0.0039
2023-08-09 2023-06-30 13F Cytokinetics Equity 23282W605 55,949 -23,779 -29.83 1,825 -34.94 0.0023
2023-05-12 2023-03-31 13F CYTOKINETICS EQUITY 23282W605 79,728 26,058 48.55 2,806 14.07 0.0039
2023-02-14 2022-12-31 13F Cytokinetics Equity 23282W605 53,670 -50,534 -48.50 2,459 -51.29 0.0038
2022-11-16 2022-09-30 13F/A-1 Cytokinetics Equity 23282W605 104,204 43,413 71.41 5,049 111.39 0.0081
2022-11-15 2022-09-30 13F Cytokinetics Equity 23282W605 104,204 43,413 5,049 0.0012
2022-08-12 2022-06-30 13F Cytokinetics Equity 23282W605 60,791 -10,294 -14.48 2,388 -8.72 0.0037
2022-05-18 2022-03-31 13F/A-1 Cytokinetics Equity 23282W605 71,085 -119,655 -62.73 2,617 -69.91 0.0035
2022-02-09 2021-12-31 13F CYTOKINETICS EQUITY 23282W605 190,740 103,685 119.10 8,694 179.43 0.0124
2021-11-16 2021-09-30 13F/A-1 CYTOKINETICS EQUITY 23282W605 87,055 53,389 158.58 3,111 367.12 0.0044
2021-11-12 2021-09-30 13F CYTOKINETICS EQUITY 23282W605 16,844 -16,822 365 0.0000
2021-08-10 2021-06-30 13F CYTOKINETICS EQUITY 23282W605 33,666 13,659 68.27 666 43.23 0.0009
2021-05-07 2021-03-31 13F CYTOKINETICS EQUITY 23282W605 20,007 10,488 110.18 465 136.04 0.0007
2021-02-10 2020-12-31 13F CYTOKINETICS EQUITY 23282W605 9,519 -7,325 -43.49 198 -45.88 0.0004
2020-10-30 2020-09-30 13F CYTOKINETICS EQUITY 23282W605 16,844 10,410 161.80 365 141.06 0.0005
2020-08-06 2020-06-30 13F CYTOKINETICS EQUITY 23282W605 6,434 -202,252 -96.92 152 -93.86 0.0003
2020-05-13 2020-03-31 13F CYTOKINETICS EQUITY 23282W605 208,686 195,837 1,524.14 2,460 1,708.82 0.0050
2020-02-12 2019-12-31 13F CYTOKINETICS EQUITY 23282W605 12,849 5,092 65.64 136 54.55 0.0002
2019-11-07 2019-09-30 13F CYTOKINETICS EQUITY 23282W605 7,757 2,650 51.89 88 54.39 0.0002
2019-07-30 2019-06-30 13F CYTOKINETICS EQUITY 23282W605 5,107 -4,464 -46.64 57 -25.97 0.0001
2019-04-25 2019-03-31 13F CYTOKINETICS EQUITY 23282W605 9,571 9,555 59,718.75 77 76,562.38 0.0002
2019-02-12 2018-12-31 13F CYTOKINETICS EQUITY 23282W605 16 -1,520 -98.96 0 -100.00 0.0000
2018-11-07 2018-09-30 13F CYTOKINETICS EQUITY 23282W605 1,536 0 0.00 15 25.00 0.0000
2018-07-25 2018-06-30 13F CYTOKINETICS EQUITY 23282W605 1,536 -13,050 -89.47 13 -88.57 0.0000
2018-05-11 2018-03-31 13F CYTOKINETICS EQUITY 23282W605 14,586 -4,727 -24.48 105 -33.12 0.0002
2018-03-05 2017-12-31 13F/A-1 CYTOKINETICS EQUITY 23282W605 19,313 -5,502 -22.17 157 -56.27 0.0003
2018-02-01 2017-12-31 13F CYTOKINETICS EQUITY 23282W605 19,313 -5,502 157
2017-11-03 2017-09-30 13F CYTOKINETICS STOCK 23282W605 24,815 11,487 86.19 360 122.98 0.0009
2017-08-03 2017-06-30 13F CYTOKINETICS STOCK 23282W605 13,328 13,036 4,464.38 161 5,266.67 0.0005
2017-05-03 2017-03-31 13F CYTOKINETICS STOCK 23282W605 292 -1,613 -84.67 4 -86.96 0.0000
2017-02-14 2016-12-31 13F CYTOKINETICS STOCK 23282W605 1,905 -376 -16.48 23 15.00 0.0001
2016-10-05 2016-09-30 13F * CYTOKINETICS INC COM STOCK 23282W605 2,281 964 73.20 21 66.67 0.0001
2016-07-06 2016-06-30 13F * CYTOKINETICS INC COM STOCK 23282W605 1,317 1,317 0.00 12 0.0001
2016-04-22 2016-03-31 13F * CYTOKINETICS INC COM STOCK 23282W605 0 -3,348 -100.00 0 -100.00
2016-04-19 2015-12-31 13F/A-1 * CYTOKINETICS INC COM STOCK 23282W605 3,348 -5,042 -60.10 35 -37.50 0.0002
2016-02-10 2015-12-31 13F * CYTOKINETICS INC COM STOCK 23282W605 3,348 35
2015-11-13 2015-09-30 13F * CYTOKINETICS INC COM STOCK 23282W605 8,390 5,504 190.71 56 194.74 0.0001
2015-08-14 2015-06-30 13F CYTOKINETICS INC COM STOCK 23282W605 2,886 2,066 251.95 19 280.00 0.0001
2015-05-15 2015-03-31 13F * CYTOKINETICS INC COM STOCK 23282W605 820 820 0.00 6 0.0000
2015-02-11 2014-12-31 13F * CYTOKINETICS INC COM STOCK 23282W605 0 -2,116 -100.00 0 -100.00
2014-11-12 2014-09-30 13F * CYTOKINETICS INC COM STOCK 23282W605 2,116 2,045 2,880.28 7 -97.94 0.0000
2014-08-14 2014-06-30 13F/A-1 * CYTOKINETICS INC COM STOCK 23282W605 71 52 273.68 0 -100.00 0.0000
2014-08-14 2014-06-30 13F CYTOKINETICS INC COM STOCK 23282W605 71 0
2014-05-13 2014-03-31 13F CYTOKINETICS STOCK 23282W605 19 -326 -94.49 0 -100.00 0.0000
2014-04-02 2013-12-31 13F/A-1 CYTOKINETICS STOCK 23282W605 345 345 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.